Stocks in play: HEXO Corp.
Has repaid the total outstanding principal amount of the Company’s 8% unsecured convertible debentures issued December 5, 2019, which matured on December 5, 2022 in the amount of C$40.14 million together with all accrued and unpaid interest. HEXO Corp. shares T.HEXO are trading unchanged at $0.24.
Read:
Latest Set of FDA Fast Track Designations Causing Optimism in Biotech Sector
Biotech Sector to Unveil New Data and Developments at 2022 SABCS in San Antonio
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer
New Biotech Sector Drug Combinations Target a Drop in Pancreatic Cancer Mortality Rates
Highly Sought After Natural Ingredients Appearing in More Plant-Based Products Across North America